JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

NEW! GSD NovaType Detect + Select SARS-CoV-2 RT-PCR for the detection of SARS-CoV-2 RNA and identification of specific variants

2021.10.26.

Product Launch: New multiplex research use only (RUO) real-time reverse transcription PCR (RT-PCR) assay designed for the simultaneous qualitative detection of SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2) genomic RNA and identification of the spike (S) gene mutations R346K and Y449H as well as the ORF1a mutation I3731V. It is intended to aid in the identification of SARS-CoV-2 variants of concern (VOC), variants of interest (VOI) and variants under monitoring (VUM). It is designed to aid investigations related to the prevalence and frequency of virus variants.

Gold Standard Diagnostics Europe is pleased to announce the launch of GSD NovaType Detect + Select SARS-CoV-2. This assay has been designed to detect SARS-CoV-2 genomic RNA and to identify Spike (S) mutations R346K and Y449H, as well as ORF1a mutation I3731V.

GSD NovaType Detect + Select SARS-CoV-2
Order No. PCOV6171- Format: 1 x 96 reactions

Assay main features:

Identification of SARS-CoV-2 N gene (targets: N1/N2) and S gene mutations in one reaction.
An optional Primer-Probe-Mix allows additional detection of the S gene mutation Y449H (only compatible with certain RT-PCR cyclers).
Specimen types: nasal lavage/swab, nasopharyngeal swab, oropharyngeal swab
Validated PCR platforms: AriaMx^TM, AriaDx^TM (Agilent Technologies)
RUO

Please contact us if you are interested in further information. We are looking forward to hearing back from you.

All new SARS-CoV-2 tests can be ordered online at our Webshop.

Back to list